In the 2023, the webcast "In the Stem Cell Jungle" hosted by Maxime Feyeux, co-founder and CSO of TreeFrog Therapeutics becomes a blog. What will you find in the Stem Cell Jungle ? #1 Exclusive & free resources: a list of cell therapy trials based on pluripotent...
Bordeaux, France, Cambridge (MA), USA / October 20th, 2022 – TreeFrog Therapeutics, a biotechnology company aimed at making safer, more efficient and more affordable cell therapies based on induced pluripotent stem cells (iPSCs), today announced that an international team composed of 3 PhD students from King’s College...
The machine will be transferred in 2023 to a contract development and manufacturing organization (CDMO) to produce TreeFrog’s cell therapy candidate for Parkinson’s disease, with the aim of a first-in-human trial in 2024. Over 2023, Invetech will deliver three additional GMP encapsulation devices to support...
https://youtu.be/w1OQqy26lvU The application form is now online, and will be available until June 30th ! Apply Now ! ...
Throughout 2022, TreeFrog Therapeutics will be connected to strategic international investors through the EIC ScaleUp initiative. Selected among 3,000+ deeptech companies funded by the €10.1 billion EIC innovation programme for European startups and SMEs, TreeFrog Therapeutics joins the EIC Scalingup TOP50 and EIC Growth Club. “TreeFrog...